Results 231 to 240 of about 251,509 (278)

The Epidemiology of Respiratory Syncytial Virus and the Impact of the COVID-19 Pandemic in a Retrospective Evaluation. [PDF]

Pathogens
Solidoro P, Curtoni A, Costa C, De Rosa FG, Bondi A, Sidoti F, Shbaklo N, Patrucco F, Favre D, Zanotto E, Corcione S, Rinaldo RF.   +11 more
europepmc   +1 more source

Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants. [PDF]

Vaccines (Basel)
Calomfirescu-Avramescu A, Toma AI, Mehedințu C, Năstase L, Dima V.   +4 more
europepmc   +1 more source

Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.

JAMA Netw Open
Surie D, Yuengling KA, Safdar B, Ginde AA, Peltan ID, Brown SM, Gaglani M, Ghamande S, Gottlieb RL, Columbus C, Mohr NM, Gibbs KW, Hager DN, O'Rourke M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Busse LW, Felzer J, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Lauring AS, Martin ET, Mosier JM, Harris ES, Baughman A, Swan SA, Johnson CA, Blair PW, Lewis NM, Ellington S, Rutkowski RE, Zhu Y, Self WH, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network.   +44 more
europepmc   +1 more source

Immunoprophylaxis for respiratory syncytial virus

The Pediatric Infectious Disease Journal, 2002
openaire   +4 more sources

Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease. [PDF]

Commun Med (Lond)
Plock N, Sachs JR, Zang X, Lommerse J, Vora KA, Lee AW, Cheung SYA, Maas BM.   +7 more
europepmc   +1 more source

Socioeconomic Inequities in the Age-Specific Burden of Severe Respiratory Syncytial Virus in Canada, 2016-2019. [PDF]

J Infect Dis
Alessandrini J, Smith BT, Fitzpatrick T, Buchan SA.   +3 more
europepmc   +1 more source

Impact of respiratory syncytial virus on Streptococcus pneumoniae resistance to β-lactam antibiotics: an investigative study in children. [PDF]

BMC Microbiol
Li L, Wan Y, Wang Y, Tao Y, Long X, Liu E, Deng Y.   +6 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants. [PDF]

Clin Drug Investig
Bini C, Marcellusi A, Cazzato D, Muzii B, Soudani S, Bozzola E, Midulla F, Baraldi E, Bonanni P, Boccalini S, Orfeo L.   +10 more
europepmc   +1 more source

Highly Effective mRNA-LNP Vaccine Against Respiratory Syncytial Virus (RSV) in Multiple Models. [PDF]

Vaccines (Basel)
Bai H, Yu X, Gao Y, Li Q, Wen B, Hu R.
europepmc   +1 more source